Riyadh to host global biotech leaders for RGMBS 2026

Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together more than 100 speakers and delegations from over 70 countries. The event is designed to advance Saudi Arabia’s biotech strategy, attract investment and connect research, industry and government across the sector.

Why it matters: - RGMBS 2026 is positioned as a major convening point for Saudi Arabia’s biotech ambitions. - The summit is tied to the kingdom’s National Biotechnology Strategy, which aims to add $34.6 billion in non-oil GDP by 2040. - The event is built to connect research, investment, regulation and manufacturing across the biotech value chain.

What happened: - Riyadh will host the Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026. - The fourth edition is expected to draw more than 15,000 visitors, over 100 local and international speakers, 200 biotech and health brands, and more than 80 government and industry exhibitors. - Delegations from more than 70 countries are expected to attend. - Organizers say they aim to sign more than 65 agreements and memorandums of understanding during the three-day event.

The details: - The summit will center on six themes: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and workforce development. - The scientific program will cover population-scale genomics, AI-driven drug discovery, local biologics manufacturing, regulatory science, commercialization and investment. - The event is organized under the supervision of the Ministry of National Guard Health Affairs. - KAIMRC and King Saud bin Abdulaziz University for Health Sciences are hosting the summit. - Strategic partners include the Ministry of Investment, Invest Saudi and the Saudi Data & AI Authority. - Registration is open for delegates, exhibitors and industry partners. - More information is available on the summit website. - The event is being promoted with the hashtag #RGMBS2026. - Contact information for further inquiries includes PR@legends.sa and +966 559 810 777.

Between the lines: - Saudi Arabia is using the summit to signal that biotech is not just a research priority, but an economic-development strategy. - The program emphasizes infrastructure, talent and regulatory capacity, suggesting the country wants to be seen as a full-stack biotech hub, not only a conference host. - Named partnerships with Harvard University, AstraZeneca and Peking University underline the summit’s push for global credibility.

What's next: - Organizers will use the event to bring researchers, investors, industry leaders and government officials into dealmaking and policy discussions. - International delegates are expected to get a closer look at Saudi Arabia’s regulatory frameworks, manufacturing infrastructure and translational research capacity. - The summit’s outcomes will likely be measured by the number of agreements signed and the visibility it gives to the kingdom’s biotech roadmap.